Smith and colleagues found that in rhesus macaques infected with a lethal dose of Ebola virus, treatment with interferon beta early after exposure led to a significant increase in survival time, although it did not reduce mortality significantly. These findings suggest that early postexposure therapy with interferon beta may be a promising adjunct in the treatment of Ebola virus infection. The experimental drug ZMapp has shown some promise, but supplies have quickly been exhausted.
For more on the treatment of patients with Ebola virus, read here.
For Medscape’s special coverage of the expanding (2014) Ebola virus outbreak, see the Ebola Resource Center.
Medscape © 2014
WebMD, LLC
Cite this: Fast Five Quiz: How Much Do You Really Know About Ebola Virus? - Medscape - Sep 22, 2014.
Comments